- Home
- ALX vs QDEL Comparison
ALX vs QDEL Comparison
Compare ALX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALX | QDEL |
|---|---|---|
| Founded | 1928 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALX | QDEL |
|---|---|---|
| Price | $250.02 | $13.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 25.0K | ★ 2.1M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.20% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 0.91 | N/A |
| Revenue | $213,183,000.00 | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $271.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $201.28 | $9.92 |
| 52 Week High | $260.84 | $35.58 |
Technical Indicators
Market Signals| Indicator | ALX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 56.30 | 59.34 |
| Support Level | $227.27 | $10.86 |
| Resistance Level | $258.70 | $17.78 |
| Average True Range (ATR) | 5.64 | 0.88 |
| MACD | 0.80 | 0.40 |
| Stochastic Oscillator | 89.53 | 89.76 |
Price Performance
Historical ComparisonAbout ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.